Other
China’s life sciences industry remains opportune despite Covid-19 coronavirus
01 April 2020 - Posted by: David Shen
While the novel Covid-19 coronavirus is at the top of the agenda for businesses around the world, and for good reason, it is creating challenges for medical and healthcare systems and signalling fundamental change across the life sciences industry. Activity in China’s life sciences market remains high as one of the few sectors to › Read More
France – Law on fighting waste and the circular economy finally enacted
27 February 2020 - Posted by: Eveline Van Keymeulen
On 10 February 2020, the French law on fighting waste and the circular economy was enacted after months of discussions between the National Assembly and the Senate – the bill had been debated since July 2019. The law contributes to the framework set out by the 2004 French Environmental Charter, and transposes some provisions of › Read More
China: Amendment to Drug Administration Law
03 September 2019 - Posted by: David Shen
On 26 August 2019, the China’s National People’s Congress passed the amended Drug Administration Law (the Amended DAL) which will take effect on 1 December. The new law brings in some changes while codifying many existing practices. We summarise in this article the key highlights, including intellectual property related rules, of the Amended DAL. 1. Redefine › Read More
Slovak government softens regulation of CBD (cannabidiol)
23 August 2019 - Posted by: Zuzana Hecko
On 21 August 2019 the Slovak government introduced a draft law which deletes CBD (cannabidiol) from the list of psychotropic substances and therefore makes CBD a non-regulated substance. CBD has been included in the list of psychotropic substances (category II) in Act No. 139/1998 (the Narcotics Act) since 2011. It was included on the list › Read More
Key developments in relation to new Chinese IP tribunal rule and Chinese patent law amendment
18 January 2019 - Posted by: David Shen
Recently, there have been some key developments in the intellectual property sphere in China that may be relevant to life sciences clients. Below we report on the new Chinese IP tribunal rule and an important Chinese patent law amendment. New Chinese IP tribunal rule The Standing Committee of the National People’s Congress previously announced the › Read More